Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

被引:0
|
作者
Jos A van der Hage
J Sven D Mieog
Marc J van de Vijver
Cornelis JH van de Velde
机构
[1] Department of Surgery,Leiden University Medical Center
[2] European Organization for Research and Treatment of Cancer Data Center,The Netherlands Cancer Institute
[3] Department of Pathology,undefined
来源
关键词
Tamoxifen; Estrogen Receptor Status; Premenopausal Patient; LHRH Agonist; Adjuvant Systemic Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Impact of adjuvant chemotherapy with respect to level of hormone receptor expression in patients with hormone responsive breast cancer: Implications for endocrine resistance
    Eralp, Y.
    Sakallioglu, B.
    Kucucuk, S.
    Tuzlali, S.
    Saip, P.
    Igci, A.
    Muslumanoglu, M.
    Aydiner, A.
    Topuz, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer
    Metzger Filho, Otto
    Ballman, Karla
    Campbell, Jordan
    Liu, Minetta
    Ligibel, Jennifer
    Watson, Mark
    Chen, Eveline
    Du, Lili
    Stover, Daniel
    Carey, Lisa
    Partridge, Ann
    Kirshner, Jeffrey
    Muss, Hyman
    Hudis, Clifford
    Winer, Eric P.
    Norton, Larry
    Symmans, W. Fraser
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (10)
  • [33] Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy
    Montemurro, Filippo
    Aglietta, Massimo
    ENDOCRINE-RELATED CANCER, 2009, 16 (04) : 1091 - 1102
  • [34] Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis
    Pajares, Bella
    Pollan, Marina
    Martin, Miguel
    Mackey, John R.
    Lluch, Ana
    Gavila, Joaquin
    Vogel, Charles
    Ruiz-Borrego, Manuel
    Calvo, Lourdes
    Pienkowski, Tadeusz
    Rodriguez-Lescure, Alvaro
    Angel Segui, Miguel
    Tredan, Olivier
    Anton, Antonio
    Ramos, Manuel
    del Carmen Camara, Maria
    Rodriguez-Martin, Cesar
    Carrasco, Eva
    Alba, Emilio
    BREAST CANCER RESEARCH, 2013, 15 (06):
  • [35] Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis
    Bella Pajares
    Marina Pollán
    Miguel Martín
    John R Mackey
    Ana Lluch
    Joaquín Gavila
    Charles Vogel
    Manuel Ruiz-Borrego
    Lourdes Calvo
    Tadeusz Pienkowski
    Álvaro Rodríguez-Lescure
    Miguel Angel Seguí
    Olivier Tredan
    Antonio Antón
    Manuel Ramos
    María del Carmen Cámara
    César Rodríguez-Martín
    Eva Carrasco
    Emilio Alba
    Breast Cancer Research, 15
  • [36] Hormone receptor status and survival of medullary breast cancer patients
    Aksoy, Asude
    Odabas, Hatice
    Kaya, Serap
    Bozkurt, Oktay
    Degirmenci, Mustafa
    Topcu, Turkan O.
    Aytekin, Aydin
    Arpaci, Erkan
    Avci, Nilufer
    Pilanci, Kezban N.
    Cinkir, Havva Y.
    Bozkaya, Yakup
    Cirak, Yalcin
    Gumus, Mahmut
    SAUDI MEDICAL JOURNAL, 2017, 38 (02) : 156 - 162
  • [37] Menstrual cycle and hormone receptor status in breast cancer patients
    Atalay, C
    Kanliöz, M
    Altinok, M
    NEOPLASMA, 2002, 49 (04) : 278 - 282
  • [38] Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients
    McCarthy, Anne Marie
    McGuire, Erin
    Bristol, Mirar
    Fredricks, Tracey
    Domchek, Susan M.
    Armstrong, Katrina
    CANCER EPIDEMIOLOGY, 2013, 37 (05) : 601 - 605
  • [39] Efficacy of HER2-targeted therapy for patients with HER2-positive breast cancer according to hormone receptor status.
    Murata, Takeshi
    Takahashi, Maiko
    Hayashida, Tetsu
    Jinno, Hiromitsu
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [40] Efficacy of chemotherapy after hormone therapy for hormone receptor-positive metastatic breast cancer
    Mori, Ryutaro
    Nagao, Yasuko
    SAGE OPEN MEDICINE, 2014, 2